Read a Venezuelan Guard's 'Chilling' Account About the Delta Force Raid That Nabbed...
Watch What Happens When This Leftist Protester Accosts a CNN Reporter in Minneapolis
Is This Why the Media Isn't Covering the Iran Protests?
We’re in a Slow-Rolling Civil War, President Trump Needs to Recognize It
The Democrats' Hamas Problem
They Can Hate Israel All They Want
The Consequences of Leftist Lawlessness
A Quick Bible Study Vol. 302: What the Bible Says About Pain
While Democrats Promote Hoaxes, Republicans Must Stand for Truth
Minneapolis Radicals Begin Distributing Devices to Disable ICE Vehicles
Sons of Liberty, Sons of Legacy: Forming the Men Who Will Shape America’s...
Banning the Muslim Brotherhood: A Good Start, Part 2
The Problem of Clergy Sowing Discord
Former DC Cop Sentenced to 27 Years for Trafficking Minors
Venezuelan National Charged in Alleged $1 Billion Crypto Money Laundering Scheme
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos